PharmiWeb

Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026

Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of € (6.5) ...
PharmiWeb

IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, SE / ACCESS Newswire / January 19, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a ...
PharmiWeb

Advicenne: FDA Has Accepted for Review the Marketing Authorization Application for Sibnayal® in the United States for the Treatment of dRTA

The US regulatory agency has set the target date for the final approval decision, known as the PDUFA date, as of September 3rd, 2026.PARIS--(BUSINESS WIRE)--Regulatory News:Advicenne (Euronext Growth ...
PharmiWeb

BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF

VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
PharmiWeb

Genflow Biosciences PLC Announces Directorate Change

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
PharmiWeb

ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...
PharmiWeb

Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today ...
PharmiWeb

Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...
PharmiWeb

Black Book Research: Rural Hospital Survey Finds Health IT Still Too Often "Urban-First," Driving Added Burden for Lean Rural Teams

Critical Access Hospital IT, clinical, and financial users cite repackaged health-system solutions, misaligned implementation ...
PharmiWeb

TRNR Publishes Shareholder Letter Updating 2025 Guidance; Highlights Wattbike Air-Pro Commercial Traction, Sportstech Enforcement Update

Pro Forma Revenue Expected to exceed $20M (~4x 2024 Revenue)Wattbike Air-Pro Sells 700+ Units / ~$2.5M in UK Commercial ...
PharmiWeb

Ombudsman’s investigation triggers review of cancer treatment wait times at NHS Trust

Ombudsman’s investigation triggers review of cancer treatment wait times at NHS Trust An investigation by England’s Health ...
PharmiWeb

Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® In Combination with Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer

ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug ...